Amyotrophic Lateral Sclerosis (ALS)

This overview focuses on Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects motor neurons responsible for voluntary muscle movement. It highlights the gradual loss of muscle control, leading to weakness, difficulty speaking, swallowing, and eventually breathing. While the exact cause remains unclear, factors such as genetic mutations, oxidative stress, and glutamate toxicity are commonly implicated. Conventional treatments aim to slow disease progression and manage symptoms. In addition, regenerative and holistic approaches are introduced to support neurological function, cellular health, and quality of life. These include Precursor Stem Cell Therapy (PSC), Mito Organelles (MO), Nano Organo Peptides (NOPs), and other integrative therapies that aim to nourish motor neurons, modulate inflammation, and enhance systemic resilience. This resource is ideal for healthcare providers, caregivers, and individuals seeking supportive strategies in the management of ALS.